Intercellular signalling is limited by the range of cell responsiveness, often mediated by repressors. A recently identified repressor, Sprouty, inhibits MAP kinase signalling in flies, mice and humans and has a conserved function in patterning the airways of these divergent species.
Most body organs arise from simple, uniform structures that increase in complexity and undergo regional differentiation as embryogenesis proceeds. These changes occur in response to controlled signalling events that act to influence cell fate, proliferation and migration. A key realisation in recent years has been that a handful of signalling pathways, including those mediated by epidermal growth factor (EGF) and fibroblast growth factor (FGF), are used in many different contexts to govern the development of a great variety of organs. A fundamental question remains: how do such signals exert such highly specific effects? And in particular, how do diffusible signals, such as EGF and FGF, provoke spatially distinctive responses? It has long been appreciated that the developmental history of the cell affects the outcome of signalling inputs. Recent studies, though, suggest that a second major contribution to signalling specificity involves the tight spatial and temporal regulation of the activity of signalling molecules.
A good example of this involves the recently identified family of sprouty-like genes. These are induced by FGF and EGF signalling, but act as antagonists of mitogen-activated protein (MAP) kinase signalling to limit the action of the very signalling events that induce them. Sprouty controls cell fate in Drosophila, by limiting the action of FGF signalling in the tracheal system [1] and the EGF pathway in the eye and other tissues [2,3,] . FGF/Sprouty signalling in the developing vertebrate lung shows striking parallels with that in the insect respiratory system [4] [5] [6] . Thus, sprouty is another example of a gene whose conservation in flies and vertebrates may underpin a conserved function.
Development of the Drosophila tracheal system
The Drosophila tracheal system develops from segmentally reiterated 'placodes' of postmitotic ectodermal cells on either side of the embryo, which invaginate to form simple sacs. These sacs branch in a precise sequence to produce a stereotyped arborisation. Primary side shoots, consisting of 'lead' cells followed by 'stalk' cells, form at specific sites. The lead cells remain at the tips of the primary branches, take on terminal cell fate and later form secondary branches. These finer branches are formed by individual terminal cells, which roll up to form a tube; later they produce multiple, fine cytoplasmic extensions, the terminal branches. The significance of such branching is that the surface area for oxygen exchange is enormously increased, just as it is by the formation of a bronchial tree and alveoli in the vertebrate lung. Remarkably in Drosophila, this expansion is achieved without cell proliferation, but results from the migration of specific lead cells and changes in cell shape [7] . At each stage, the initiation of branches depends on the specification of particular cell types; first lead cells initiate primary branches and later, when they progress to a terminal cell fate, they produce secondary and finally terminal branches.
Clearly, to be effective in increasing the surface area of the respiratory tissue, such branching must be tightly regulated. If too few branch sites are initiated, the surface area is hardly increased, but if branch initiation is ubiquitous, there is no branching; a mitten rather than a glove is made. Branching thus depends on the differential specification of branch-forming and non-branch-forming cells, and demands precise patterning of cell fate so that branch initiation is localised and specific.
FGF in the tracheal system
Both primary and secondary branches are promoted by Branchless, a Drosophila FGF that is expressed in cells surrounding the tracheal epithelium, in a pattern that prefigures sites of branch initiation [8] . The receptor for Branchless is Breathless, a Drosophila FGF receptor which is expressed throughout the tracheal epithelium. The activation of Branchless initiates the remodelling of the epithelium to produce branches, but, significantly, it also leads to the expression of target genes such as pointed, which is required to form secondary branches, and pruned -which encodes the Drosophila serum response factor, (SRF) -which is required for terminal branch formation [9] . FGF signalling thus underlies the formation of each branch type, so that in mutants lacking either branchless or breathless function the tracheal system in each segment remains as discrete, unbranched sacs [8, 10] .
Conversely, overproduction of Branchless, or of a constitutively-active form of its receptor, produces myriad fine branches, arising all along the primary branches [7, 8] . The normal pattern of tracheal arborisation thus develops only if restrictions operate on FGF signalling. Clearly this is achieved initially by controlling precisely which cells flanking the developing tracheal epithelium express branchless. Such precision might be dictated by the same genes that pattern the antero-posterior and dorso-ventral axes in Drosophila [11] . Temporal restrictions also appear to operate; the expression of FGF is short-lived, so that as epithelial branches extend towards patches of branchlessexpressing cells, production of the signal declines ( Figure 1a ) [8] . FGF signalling is thus normally tightly controlled in both space and time.
Sprouty: a widely acting repressor
The discovery of sprouty, which encodes an inhibitor of FGF signalling, has uncovered a feedback mechanism that confers spatial separation of branch sites. Sprouty is expressed by the tracheal epithelial cells in response to FGF and acts to repress further branch formation [1] . As its name suggests, loss of sprouty function allows the growth of multiple fine branches from the stalks of primary branches. Hacohen et al. [1] found that loss of sprouty deregulates FGF signalling, resulting in a cell fate change in stalk cells so that they express pointed and pruned and are recruited to the branching fate. Genetic analysis showed that Sprouty acts non-cell-autonomously to repress the branch-forming fate in cells adjacent to those stimulated by FGF, an outcome akin to lateral inhibition ( Figure 1a ).
Sprouty has recently been found to work in other signalling systems. Casci et al. [2] and Kramer et al. [3] have shown that it represses the EGF signalling pathway that is required for cell-fate specification in the Drosophila eye [12] . Intriguingly, in this system Sprouty appears to act cell autonomously. The Drosophila eye is made up of multiple ommatidial facets, each a minute light-collecting unit with photoreceptors, cone cells and pigment cells. Without EGF receptor activation, none of these cell types is recruited and the eye fails to develop. The extent of EGF signalling is restricted by the activity of the inhibitor Argos: argos is induced by EGF signalling; its product is secreted from activated cells and acts to impose a spatial restriction on EGF receptor activation ( Figure 2a ) [12, 13] .
Two recent papers [2, 3] identify sprouty as a second inhibitor of EGF signalling in the eye. Loss of sprouty results in the recruitment of supernumerary cells of each type in the ommatidium, as a result of overstimulation of the EGF pathway. Genetic analysis showed that sprouty expression is dependent on activation of the EGF pathway, and that Sprouty represses EGF receptor signalling. Kramer et al. [3] showed further that Sprouty limits EGF signalling in other tissues, such as the ovary and nervous system, suggesting that it might function widely in tissue differentiation. Sprouty thus acts in a negative feedback loop that limits signalling through at least two receptor tyrosine kinases, the FGF and EGF receptors.
How does Sprouty antagonise FGF and EGF signalling?
The first clue came from the observation that Sprouty acts cell autonomously in the eye; in an eye with a mixed population of wild-type and mutant cells, it is the mutant cells that are mis-specified [2, 3] , suggesting that Sprouty prevents an inappropriate response to EGF signalling. As all receptor tyrosine kinases have a common intracellular pathway -the MAP kinase cascade -negative feedback at the level of signal transduction would explain the broad spectrum of Sprouty's effects. Casci et al. [3] have shown that Sprouty acts downstream of the EGF receptor but upstream of Ras and MAP kinase; it associates with the intracellular face of the membrane, and is able to bind Drk (the Drosophila homologue of the adaptor protein Grb2) and Gap1, a negative regulator of Ras activity. They suggest that Sprouty regulates Ras activity by binding Gap1 and blocking recruitment of positive regulators of signalling, such as the Ras-activating protein, Sos.
How does Sprouty act to determine cell fate?
As outlined above, there is an important difference between the way Sprouty works in the eye and in the tracheal system: it acts cell autonomously in the former case, but non-autonomously in the latter. How does Sprouty exert its effect on cell signalling, and thus on cell fate, in these different ways? There are a number of possible ways in which cell signalling can establish cell fate, but their common outcome is to set critical levels of intracellular regulators that induce stable changes in gene expression. The critical levels of such regulators are themselves likely to be set by the intensity of signalling or by multiple inputs that integrate to alter their expression or activity.
The range and potency of signalling can be limited in a variety of ways (Figure 2) , all of which act to reduce the build-up of these active regulators. Where the repressor acts back on the pathway that induces it, a negative feedback loop is set up. Which of the various possibilities applies to Sprouty? If Sprouty acts intracellularly to repress signal transduction, it is not difficult to see how its effects can be cell autonomous, as in the eye (Figure 2c ). But how does it impose non-cell-autonomous effects, as in the tracheal system? Here, Sprouty may control a second signalling relay, which represses cell fate in the neighbours of Sprouty-expressing cells (Figure 2b ), in a manner reminiscent of lateral inhibition by Notch and Delta. Indeed, Delta and Notch are required for the normal segregation of terminal cells in the tracheal system [14] , though how this relates to Sprouty action is not yet clear.
Why are there two different repressive regimes, both mediated by Sprouty in response to receptor activation? In the tracheal system, FGF signalling acts repeatedly on the same cells, each time initiating a different response. First, signalling from a point source identifies lead cells in the sacs. These cells migrate towards the FGF source, maximising their exposure to the signal. The resulting high levels of FGF signalling induce expression of pointed, which promotes the cell-shape changes that drive secondary branch formation. Later, FGF signalling acts on these same cells to induce the fine terminal projections. At each stage, the response to FGF is limited to one or two cells that are closest to the FGF source. Two factors may contribute to this restriction: proximity to the source, so the responding cells are the only ones exposed to high enough FGF levels; and repression of FGF responsiveness in flanking cells by Sprouty-induced inhibition. A dual system of this kind operates in the selection of cell fates in the nematode vulva, where proximity to the anchor cell sets the primary versus secondary cell fates, but these decisions are reinforced by lateral signalling between the specified cells [15] .
In contrast, in the eye there are waves of EGF signalling and each wave sets the fate of different cell types in the ommatidium. Spatial restriction of EGF signalling is imposed by Argos secretion, but Sprouty seems to set a temporal limit to the responsiveness of EGF-activated cells; part of a cell's response to EGF is to induce Inductive interactions can be limited in a number of ways. An early response to the activation of a signalling pathway can be the induction and secretion of an antagonist (red) that either (a) diffuses more rapidly than the signal (green) and so outcompetes it, or (b) activates a relay involving a second pathway, whose effect is to antagonise the first. (c) In a third mechanism, intracellular repressors that block signal transduction can be activated by the signalling pathway they repress, to induce a refractory period.
(a) Receptor inhibition (b) Transduction inhibition (c) Cell autonomous repression
Current Biology cell-autonomous repression that shuts off its own responsiveness to further signalling (Figure 2c ). In this way, each cell responds once and only once to EGF. The induction of such a refractory state was implicit in the model proposed for cell-fate patterning through reiterative EGF signalling when this system was first described [12] .
There remains a paradox, which is germane to negative feedback loops in general: how do cells stimulated by FGF and EGF maintain their activated state once they start expressing the pathway inhibitor? The question is how a balance is achieved between the activation and the repression set up by the same signalling event. On the face of it, a cell receiving highest levels of the activation signal will also be exposed to highest levels of the inhibitor. The paradox can be resolved by taking the timing of events into account. For example, cells exposed to EGF start to differentiate and, as part of their differentiation program, begin to produce the inhibitor Argos. Argos is secreted and diffuses more rapidly than the signal, preventing neighbouring cells from responding to EGF. The outcome of signalling thus depends on the time required for a cell to become irreversibly committed: if it takes less time than that required for the inhibitor to accumulate to functional levels, the cell is activated; if not, the cell is inhibited.
The fact that branches do form in the tracheal system and cells adopt specific fates in the eye demonstrates that FGF and EGF signalling is not completely repressed by Sprouty in these systems; the inhibitor must accumulate slowly enough to allow cell activation. In the eye, cells do not respond a second time to EGF, so the refractory state persists, but in the tracheal system, lead cells become terminal cells, which are responsive to later FGF signalling. As the expression of FGF in cells flanking the tracheal epithelium is short-lived, the initial induction of Sprouty expression wanes, leaving the terminal cells unrepressed and sensitive to FGF once again.
Development of the vertebrate lung
A remarkable conservation exists between the pathways governing Drosophila tracheal development and vertebrate lung development. The vertebrate lung develops from two epithelial buds that form as outpocketings from the foregut, surrounded by mesenchyme. Each bud elongates; as it grows, secondary lateral buds sprout at specific distances from the leading tip; in turn, these elongate and sprout tertiary buds; and so on. A second phase of branching occurs, in which the terminal bud bifurcates into two branches. Together, these two reiterated mechanisms of lateral sprouting and dichotomous branching dictate the stereotyped ramification of the lung lobes. Lateral branches form only at specific distances from the distal tip, suggesting that new bud formation close to the tip is normally inhibited [7, 16] .
The first suggestion of parallels between the lung and the Drosophila tracheal system came from grafting experiments showing that interactions between the epithelium and the mesenchyme govern the branching pattern of the epithelium [7, 16] . The precise outcome of this interaction is complex as, in contrast to the post-mitotic Drosophila tracheal system, the branching lung epithelium is proliferative. Nonetheless, parallels between the systems were emphasised by the discovery some years ago that FGF signalling -specifically FGF10 signalling -plays a role in lung branching morphogenesis. FGF10 is expressed in the mesenchyme adjacent to the distal tips, in a dynamic fashion that predicts the location of bud outgrowth (Figure 1b) . The expression does not directly abut the epithelium -instead there is a characteristic gap. The bud grows into this gap, and towards the domain of highest FGF10 expression. As this occurs, the pattern of FGF10 expression changes, extending caudally to prefigure the outgrowth of the next bud.
In FGF10 knockout mice, the lungs are absent, the trachea ending in a cul-de-sac, demonstrating the requirement for FGF10 in vivo [4] . Conversely, in vitro, FGF10 can promote extensive bud outgrowth in cultures of lung endoderm, denuded of mesoderm [16] , and FGF10-soaked beads direct ectopic bud outgrowth when implanted in vivo [17, 18] . Transgenic mice expressing a dominant-negative form of the FGF10 receptor, Fgfr2-IIIb, show a severe inhibition of branching, suggesting that this receptor may transduce FGF10 signalling in the embryonic lung [5] . So FGF10 appears to act reiteratively to direct the early branching of the lung -the spatial restriction in FGF10 expression being key to the branching pattern. The factors that initially establish FGF10 expression are unclear, but once initiated, the expression is modulated by reciprocal interactions with the lung endoderm, in which Sonic hedgehog is proposed to play an important role, acting as a negative feedback signal that shuts off FGF10 expression (Figure 1b) [19] .
The parallels between branching morphogenesis in the vertebrate lung and insect tracheal systems have been further underscored by the realisation that, in addition to its chemotropic-like effect on bud outgrowth, FGF10 induces the production of proteins in the branch tips that are key to branch formation. Amongst these is BMP4, a secreted factor that inhibits proliferation of the epithelium and so may limit branch growth (Figure 1b) [20] . In addition, recent work has identified a sprouty homologue in mouse, Sprouty-2, the expression profile of which suggests that it might be induced in response to FGF10 signalling [6] . Sprouty-2 expression is highly localised to the lung epithelial cells, and its product appears to act, like Drosophila Sprouty, to limit branch formation (Figure 1b) . The gene has not yet been knocked out, but a 96% reduction in expression, by using antisense oligonucleotides, caused an extensive increase in terminal branching and cell proliferation [6] . In the intact embryo, therefore, Sprouty-2 may be a negative regulator of FGF signalling, reducing bud formation and so shaping lung bud arborisation.
Concluding remarks
The studies of sprouty in widely divergent species illustrate a number of principles that may well give rise to generally applicable paradigms. First, the Sprouty/FGF story is a further example of conservation of gene function between Drosophila and vertebrates. Against all expectations, the development of specific structures, such as the eye, the heart and even the nervous system, depends on genes whose activities demonstrate functional conservation. Second, although studies to date have focussed on the role of sprouty in the respiratory system and the eye, it is likely that sprouty genes work in a similar way in other systems. Other vertebrate Sprouty genes are widely expressed in the embryo, in regions that include the primitive streak, the rostral forebrain and the limb ( [21] and G. Martin and M. Krasnow, personal communication). Previous studies have revealed a role for FGF signalling in the development of all three regions, so FGF in each region may be modulated by the the Sprouty repressor.
Finally, sprouty provides an elegant example of a basic principle that potent signalling is self-regulating and the very act of signalling sets up its own (often multiple) repression. Other examples of such a mechanism have recently been uncovered: in Drosophila, the signalling protein Hedgehog (Hh) induces expression of its own receptor, patched, a negative regulator of the hh pathway [22] . In Xenopus, nodal signalling is thought to act upstream of cerberus, an antagonist. But here cerberus antagonises not only nodal, but also BMP and Wnt signalling pathways [23] . Sprouty illustrates yet a third variation, in which a common repressor can be induced by a variety of signals. Overall, then, sprouty takes its place within a structurally diverse class of signalling repressors, whose common characteristic is that they act as dampers on the conversations that take place between cells.
